Quantcast

Latest Merck Stories

2014-09-22 20:23:59

NEW YORK, Sept. 22, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Sigma-Aldrich Corporation ("Sigma-Aldrich" or "the Company") (NasdaqGS: SIAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to German drug company Merck. http://photos.prnewswire.com/prnvar/20120409/MM84375LOGO Click here to learn more about the investigation:...

2014-09-19 12:25:36

Culinary Expert Visits San Diego County on September 20 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J., Sept. 19, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, is teaming with celebrity chef and cookbook author Leticia Moreinos Schwartz on Desafiando La Diabetes: Logra Tus Metas, an educational program encouraging Hispanics with type 2 diabetes to achieve better...

2014-09-19 04:21:46

ROCKLAND, Massachusetts, September 19, 2014 /PRNewswire/ -- - The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting - Investment supports innovative projects for the advancement of science and medical research in the field of growth EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the first recipients of the Grant for Growth Innovation (GGI) for...

2014-09-18 12:29:37

DARMSTADT, Germany, September 18, 2014 /PRNewswire/ -- - Stefan Oschmann appointed Deputy CEO and Vice Chairman of the Executive Board - Belen Garijo appointed new member of the Executive Board - Changes effective from January 1, 2015 Merck KGaA today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belen Garijo (54) was...

2014-09-17 08:29:31

- Collaboration and license agreement allows the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline SAN FRANCISCO, Sept. 17, 2014 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and...

2014-09-17 08:29:05

DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected such as the brain and the digestive system. Hepatitis C virus is an RNA virus belonging to the family...

2014-09-12 12:25:16

DARMSTADT, Germany, September 12, 2014 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, announced today that its biopharmaceutical division will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage III non-small cell lung cancer (NSCLC). Luciano Rossetti, Global Head of Research & Development at the biopharmaceutical division, said: "While the data...

2014-09-12 08:25:21

- Research grants awarded for five out of more than 200 proposals, highlighting continued commitment to multiple sclerosis (MS) ROCKLAND, Mass., Sept. 12, 2014 /PRNewswire/ -- EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the recipients of the second annual Grant for Multiple Sclerosis Innovation (GMSI) at the 2014 Joint ACTRIMS-ECTRIMS Meeting of the Americas Committee for Treatment and Research in MS (ACTRIMS) and European Committee for Treatment and...

2014-09-11 12:22:23

-- Providing IVF clinicians objective embryo viability data and another tool to support patient outcomes MISSISSAUGA, ON, Sept. 11, 2014 /CNW/ - EMD Serono, Canada, a subsidiary of Merck KGaA Darmstadt, Germany announced today the launch of the Eeva (®) Test in Canada. In April, Merck Serono, a biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced an exclusive licensing agreement with Auxogyn Inc. for the rights to commercialize the Eeva (®) Test in Europe...

2014-09-10 08:32:02

- EMD Serono provides funding for ACP's multicenter longitudinal OPT-UP clinical study ROCKLAND and WALTHAM, Mass., Sept. 10, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and the Accelerated Cure Project for Multiple Sclerosis today announced a lead founding sponsor agreement to help launch the Optimizing Treatment--Understanding Progression (OPT-UP) study. http://photos.prnewswire.com/prnvar/20140902/141783...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.